These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
311 related items for PubMed ID: 19223625
1. A small-molecule dengue virus entry inhibitor. Wang QY, Patel SJ, Vangrevelinghe E, Xu HY, Rao R, Jaber D, Schul W, Gu F, Heudi O, Ma NL, Poh MK, Phong WY, Keller TH, Jacoby E, Vasudevan SG. Antimicrob Agents Chemother; 2009 May; 53(5):1823-31. PubMed ID: 19223625 [Abstract] [Full Text] [Related]
2. Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein. Zhou Z, Khaliq M, Suk JE, Patkar C, Li L, Kuhn RJ, Post CB. ACS Chem Biol; 2008 Dec 19; 3(12):765-75. PubMed ID: 19053243 [Abstract] [Full Text] [Related]
3. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus. Leal ES, Adler NS, Fernández GA, Gebhard LG, Battini L, Aucar MG, Videla M, Monge ME, Hernández de Los Ríos A, Acosta Dávila JA, Morell ML, Cordo SM, García CC, Gamarnik AV, Cavasotto CN, Bollini M. Eur J Med Chem; 2019 Nov 15; 182():111628. PubMed ID: 31472473 [Abstract] [Full Text] [Related]
4. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Kampmann T, Yennamalli R, Campbell P, Stoermer MJ, Fairlie DP, Kobe B, Young PR. Antiviral Res; 2009 Dec 15; 84(3):234-41. PubMed ID: 19781577 [Abstract] [Full Text] [Related]
5. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein. Lian W, Jang J, Potisopon S, Li PC, Rahmeh A, Wang J, Kwiatkowski NP, Gray NS, Yang PL. ACS Infect Dis; 2018 Sep 14; 4(9):1395-1406. PubMed ID: 30027735 [Abstract] [Full Text] [Related]
6. A small molecule fusion inhibitor of dengue virus. Poh MK, Yip A, Zhang S, Priestle JP, Ma NL, Smit JM, Wilschut J, Shi PY, Wenk MR, Schul W. Antiviral Res; 2009 Dec 14; 84(3):260-6. PubMed ID: 19800368 [Abstract] [Full Text] [Related]
7. Discovery of novel dengue virus entry inhibitors via a structure-based approach. Leal ES, Aucar MG, Gebhard LG, Iglesias NG, Pascual MJ, Casal JJ, Gamarnik AV, Cavasotto CN, Bollini M. Bioorg Med Chem Lett; 2017 Aug 15; 27(16):3851-3855. PubMed ID: 28668194 [Abstract] [Full Text] [Related]
8. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein. de Wispelaere M, Lian W, Potisopon S, Li PC, Jang J, Ficarro SB, Clark MJ, Zhu X, Kaplan JB, Pitts JD, Wales TE, Wang J, Engen JR, Marto JA, Gray NS, Yang PL. Cell Chem Biol; 2018 Aug 16; 25(8):1006-1016.e8. PubMed ID: 29937406 [Abstract] [Full Text] [Related]
9. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach. Aarthy M, Singh SK. Curr Top Med Chem; 2018 Aug 16; 18(18):1585-1602. PubMed ID: 30360716 [Abstract] [Full Text] [Related]
10. Narasin, a novel antiviral compound that blocks dengue virus protein expression. Low JS, Wu KX, Chen KC, Ng MM, Chu JJ. Antivir Ther; 2011 Aug 16; 16(8):1203-18. PubMed ID: 22155902 [Abstract] [Full Text] [Related]
11. Small-molecule inhibitors of dengue-virus entry. Schmidt AG, Lee K, Yang PL, Harrison SC. PLoS Pathog; 2012 Aug 16; 8(4):e1002627. PubMed ID: 22496653 [Abstract] [Full Text] [Related]
12. A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses. Yang CC, Hu HS, Lin HM, Wu PS, Wu RH, Tian JN, Wu SH, Tsou LK, Song JS, Chen HW, Chern JH, Chen CT, Yueh A. Antiviral Res; 2019 Dec 16; 172():104636. PubMed ID: 31654671 [Abstract] [Full Text] [Related]
13. Structure-based drug design for envelope protein E2 uncovers a new class of bovine viral diarrhea inhibitors that block virus entry. Pascual MJ, Merwaiss F, Leal E, Quintana ME, Capozzo AV, Cavasotto CN, Bollini M, Alvarez DE. Antiviral Res; 2018 Jan 16; 149():179-190. PubMed ID: 29031833 [Abstract] [Full Text] [Related]
14. Carbohydrate-related inhibitors of dengue virus entry. Hidari KI, Abe T, Suzuki T. Viruses; 2013 Feb 06; 5(2):605-18. PubMed ID: 23389466 [Abstract] [Full Text] [Related]
15. Structure-based screening and validation of potential dengue virus inhibitors through classical and QM/MM affinity estimation. Ahmed M, Kumar A, Hobman TC, Barakat K. J Mol Graph Model; 2019 Jul 06; 90():128-143. PubMed ID: 31082639 [Abstract] [Full Text] [Related]
16. The Antimalarial Compound Atovaquone Inhibits Zika and Dengue Virus Infection by Blocking E Protein-Mediated Membrane Fusion. Yamamoto M, Ichinohe T, Watanabe A, Kobayashi A, Zhang R, Song J, Kawaguchi Y, Matsuda Z, Inoue JI. Viruses; 2020 Dec 21; 12(12):. PubMed ID: 33371476 [Abstract] [Full Text] [Related]
17. A novel flavanone derivative inhibits dengue virus fusion and infectivity. Srivarangkul P, Yuttithamnon W, Suroengrit A, Pankaew S, Hengphasatporn K, Rungrotmongkol T, Phuwapraisirisan P, Ruxrungtham K, Boonyasuppayakorn S. Antiviral Res; 2018 Mar 21; 151():27-38. PubMed ID: 29360474 [Abstract] [Full Text] [Related]
18. Progress in the identification of dengue virus entry/fusion inhibitors. De La Guardia C, Lleonart R. Biomed Res Int; 2014 Mar 21; 2014():825039. PubMed ID: 25157370 [Abstract] [Full Text] [Related]
19. How small-molecule inhibitors of dengue-virus infection interfere with viral membrane fusion. Chao LH, Jang J, Johnson A, Nguyen A, Gray NS, Yang PL, Harrison SC. Elife; 2018 Jul 12; 7():. PubMed ID: 29999491 [Abstract] [Full Text] [Related]
20. Characterization of the mode of action of a potent dengue virus capsid inhibitor. Scaturro P, Trist IM, Paul D, Kumar A, Acosta EG, Byrd CM, Jordan R, Brancale A, Bartenschlager R. J Virol; 2014 Oct 12; 88(19):11540-55. PubMed ID: 25056895 [Abstract] [Full Text] [Related] Page: [Next] [New Search]